Aviva Industries reported a standalone net profit of ₹60.36 lakh for Q1FY27, representing a 35% decline from the ₹92.83 lakh profit recorded in Q4FY26. Despite this quarterly decline, the company achieved a significant improvement from the net loss of ₹11.22 lakh reported in the corresponding quarter of the previous year. The company's revenue from operations fell 39% quarter-on-quarter to ₹3977.49 lakh from ₹6497.61 lakh in Q4FY26, while total expenses decreased to ₹3895.94 lakh from ₹6368.93 lakh in the previous quarter. The company operates within the "Trading of Agriculture Product" segment and reported minimal employee benefits expenses of ₹1.68 lakh.
Statutory auditors S K Bhavsar & Co issued a review report with significant "Emphasis of Matter" clauses, highlighting critical verification issues that raise serious governance concerns. The auditors expressed inability to verify the end-utilization of ₹22.39 crore raised through warrant conversions as sales and purchase invoices were not made available for full verification. Most notably, the company provided interest-free advances aggregating ₹26.10 crore during the quarter without supporting documentation, forcing auditors to express inability to comment on recoverability and business rationale. The auditors also could not verify physical stock/inventory as of June 30, 2026, with no Management Representation Letter confirming its existence, preventing comment on inventory existence and valuation. Additional discrepancies included the inability to obtain confirmations for certain trade receivable and payable balances due to inadequate alternative procedures.
During Q1FY27, the company converted 79,95,000 warrants into equity shares, raising ₹22.39 crore comprising face value and share premium of ₹18.00 per share. The paid-up equity share capital increased to ₹3249.90 lakh from ₹2450.40 lakh in the prior quarter. The company's operating profit margin (OPM) stood at 2.04% with PBDT of ₹0.81 crore and PBT of ₹0.81 crore, demonstrating improved operational efficiency despite the revenue decline. Total income remained at ₹3977.49 lakh with other income negligible at ₹0.00 lakh. Expenses were driven primarily by purchases of stock-in-trade, which stood at ₹4204.95 lakh, offset by a decrease in inventories of ₹325.64 lakh. Employee benefits expenses were minimal at ₹1.68 lakh, while other expenses totaled ₹14.95 lakh.
The Board of Directors approved the unaudited financial results on August 11, 2026, in compliance with Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were prepared in accordance with Indian Accounting Standards (Ind AS) notified under section 133 of the Companies Act, 2013. The divergence between the substantial capital raise of ₹22.39 crore and the simultaneous extension of ₹26.10 crore in undocumented interest-free advances raises questions about working capital management. The inability to verify core assets like inventory and receivables suggests a disconnect between reported financial health and verifiable operational data, warranting close scrutiny by investors regarding asset security and earnings quality. Reliable value and supporting documents for investments were also not presented, forcing reliance on management representations.
